Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#171 / 200 Total
MMLP - Martin Midstream Partners LP - Stock Price Chart
TickerMMLP [NASD]
CompanyMartin Midstream Partners LP
CountryUSA
IndustryOil & Gas Midstream
Market Cap109.22MEPS (ttm)0.10
P/E29.23EPS this Y227.27%
Forward P/E12.73EPS next Y57.14%
PEG8.12EPS past 5Y-
P/S0.15EPS next 5Y3.60%
P/B-EPS Q/Q164.25%
Dividend0.71%Sales Q/Q-26.05%
Insider Own28.25%Inst Own35.14%
Insider Trans0.95%Inst Trans1.12%
Short Float0.19%EarningsApr 17/a
Analyst Recom3.00Target Price3.50
Avg Volume46.67K52W Range1.95 - 3.30
Apr-19-24 08:43AM Martin Midstream Partners L.P. (NASDAQ:MMLP) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:03AM Martin Midstream Partners LP (MMLP) Q1 2024 Earnings Call Transcript Highlights: Mixed Results ... (GuruFocus.com)
Apr-18-24 10:44PM Q1 2024 Martin Midstream Partners LP Earnings Call (Thomson Reuters StreetEvents)
Apr-17-24 08:53PM MMLP Stock Earnings: Martin Midstream Partners Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:34PM Martin Midstream Partners LP Reports Q1 2024 Results: A Close Call with Analyst Estimates (GuruFocus.com)
04:01PM Martin Midstream Partners Reports First Quarter 2024 Financial Results and Declares Quarterly Cash Distribution (Business Wire)
08:50AM Why Fast-paced Mover Martin Midstream Partners (MMLP) Is a Great Choice for Value Investors (Zacks)
Apr-04-24 11:00AM Martin Midstream Partners L.P. Sets Date for Release of First Quarter 2024 Financial Results and Conference Call (Business Wire)
Mar-14-24 11:04AM Martin Midstream Partners L.P. Tax Packages Now Available (Business Wire)
Feb-26-24 02:58PM Martin Midstream Partners L.P. Update on Availability of 2023 K-1 (Business Wire)
JAN - JanOne Inc - Stock Price Chart
TickerJAN [NASD]
CompanyJanOne Inc
CountryUSA
IndustryBiotechnology
Market Cap32.95MEPS (ttm)-3.23
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q80.97%
Dividend-Sales Q/Q-
Insider Own11.05%Inst Own3.61%
Insider Trans0.00%Inst Trans-7.88%
Short Float1.93%Earnings-
Analyst Recom-Target Price-
Avg Volume339.71K52W Range0.22 - 5.26
May-03-24 10:52PM JAN Stock Earnings: JanOne Reported Results for Q1 2024 (InvestorPlace)
Mar-15-24 09:00AM JanOne Regains Compliance with Nasdaq's Listing Requirements (PR Newswire)
Nov-09-23 08:05AM Why Is JanOne (JAN) Stock Up 40% Today? (InvestorPlace) +64.75%
Sep-21-23 11:30AM JanOne to Present at the Dawson James 8th Annual Investment Conference (PR Newswire)
09:35AM Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Aug-31-23 01:30PM JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference (PR Newswire) -23.58%
Aug-29-23 01:30PM JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain (PR Newswire)
Aug-25-23 02:30PM JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
Aug-22-23 05:30PM JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire) -6.31%
Aug-18-23 07:00PM JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire) +5.64%
TTOO - T2 Biosystems Inc - Stock Price Chart
TickerTTOO [NASD]
CompanyT2 Biosystems Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap19.45MEPS (ttm)-145.61
P/E-EPS this Y74.36%
Forward P/E-EPS next Y76.01%
PEG-EPS past 5Y68.62%
P/S2.71EPS next 5Y-
P/B-EPS Q/Q98.19%
Dividend-Sales Q/Q-69.38%
Insider Own90.77%Inst Own3.58%
Insider Trans0.00%Inst Trans23.13%
Short Float73.43%EarningsMay 06/a
Analyst Recom3.00Target Price3.50
Avg Volume307.10K52W Range2.60 - 70.00
Apr-24-24 09:00AM T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024 (GlobeNewswire)
Apr-23-24 07:39AM Top Premarket Decliners (MT Newswires) -13.92%
Apr-11-24 04:05PM T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity (GlobeNewswire)
Mar-28-24 09:00AM T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. (GlobeNewswire)
Mar-20-24 07:30AM T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates (GlobeNewswire) -10.89%
Mar-19-24 09:00AM T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates (GlobeNewswire) -11.20%
Mar-18-24 09:00AM T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel (GlobeNewswire) -5.98%
Mar-12-24 03:16PM TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance (InvestorPlace)
09:00AM T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement (GlobeNewswire)
Feb-16-24 09:29AM T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.71%
ADAP - Adaptimmune Therapeutics Plc ADR - Stock Price Chart
TickerADAP [NASD]
CompanyAdaptimmune Therapeutics Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap265.79MEPS (ttm)-0.52
P/E-EPS this Y-467.56%
Forward P/E-EPS next Y-15.85%
PEG-EPS past 5Y10.30%
P/S4.38EPS next 5Y1.00%
P/B6.73EPS Q/Q-18.55%
Dividend-Sales Q/Q-97.90%
Insider Own11.90%Inst Own50.24%
Insider Trans-0.61%Inst Trans-0.50%
Short Float1.58%EarningsMar 06/b
Analyst Recom2.14Target Price3.50
Avg Volume1.58M52W Range0.42 - 2.05
May-01-24 12:00PM Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024 (Newsfile)
Apr-23-24 07:45AM Garry Menzel joins GHO Capital as Operating Partner (GlobeNewswire) +12.87%
Apr-15-24 02:12PM Adaptimmune (ADAP) Down on End of Collaboration With Roche (Zacks) -9.48%
Apr-12-24 08:00AM Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated (Newsfile) -10.08%
05:37AM Roche, Adaptimmune part ways on cell therapy research (BioPharma Dive)
Mar-27-24 07:30PM Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet (Newsfile)
Mar-07-24 01:42PM Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
08:24AM Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 12:52PM ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) +17.12%
07:00AM Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates (Newsfile)
FEMY - Femasys Inc - Stock Price Chart
TickerFEMY [NASD]
CompanyFemasys Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap29.89MEPS (ttm)-0.94
P/E-EPS this Y27.15%
Forward P/E-EPS next Y42.93%
PEG-EPS past 5Y0.85%
P/S27.93EPS next 5Y-
P/B1.59EPS Q/Q16.97%
Dividend-Sales Q/Q-9.02%
Insider Own7.80%Inst Own6.71%
Insider Trans0.00%Inst Trans4.52%
Short Float5.82%EarningsMar 28/a
Analyst Recom1.00Target Price9.75
Avg Volume708.32K52W Range0.25 - 4.75
May-02-24 10:01AM Will Femasys Inc. (FEMY) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-18-24 08:30AM Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiatives (GlobeNewswire)
Mar-28-24 10:53PM FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) +5.44%
04:05PM Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update (GlobeNewswire)
Mar-21-24 09:00AM Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape (GlobeNewswire)
Mar-20-24 08:15AM Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed for the Treatment of Infertility (GlobeNewswire) -10.00%
Mar-13-24 09:00AM Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 (GlobeNewswire) -5.24%
Mar-06-24 09:00AM Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution (GlobeNewswire) -11.27%
Feb-28-24 09:00AM Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF (GlobeNewswire) +9.26%
Feb-06-24 08:30AM Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer (GlobeNewswire) +13.27%
GLT - Glatfelter Corporation - Stock Price Chart
TickerGLT [NYSE, RUT]
CompanyGlatfelter Corporation
CountryUSA
IndustryPaper & Paper Products
Market Cap76.08MEPS (ttm)-1.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y15.44%
P/S0.05EPS next 5Y0.20%
P/B0.30EPS Q/Q74.90%
Dividend-Sales Q/Q-14.31%
Insider Own3.37%Inst Own79.94%
Insider Trans0.00%Inst Trans-4.01%
Short Float6.61%EarningsMay 09/b
Analyst Recom1.00Target Price9.00
Avg Volume1.62M52W Range1.25 - 4.19
Apr-24-24 04:03PM Citi Eyes $2 Billion Debt Package for Berry, Glatfelter Deal (Bloomberg)
Apr-17-24 07:15AM Berry and Glatfelter Announce Regulatory Milestone in Proposed Transaction for Spin-Off and Merger of Berry's Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter (Business Wire) -7.50%
Apr-11-24 06:50AM Glatfelter Announces Key Leadership Appointments in Connection With Proposed Merger With Berry's Health, Hygiene, and Specialties Global Nonwovens and Films Business (GlobeNewswire)
Apr-04-24 03:06PM Glatfelter Corporation to Report Earnings on May 9th (GlobeNewswire)
Feb-26-24 03:44PM Kuehn Law Encourages AGTI, GLT, NGM, and AA Investors to Contact Law Firm (GlobeNewswire)
Feb-23-24 10:52AM Glatfelter Corporation (NYSE:GLT) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:27AM Q4 2023 Glatfelter Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 04:45PM Glatfelter (GLT) Q4 2023 Earnings Call Transcript (Motley Fool)
06:52AM Glatfelter Reports Fourth Quarter and Year End 2023 Results (GlobeNewswire)
Feb-08-24 12:26PM Kuehn Law Encourages PGTI, AMAM, JNPR, and GLT Investors to Contact Law Firm (GlobeNewswire) -15.91%
TWST - Twist Bioscience Corp - Stock Price Chart
TickerTWST [NASD, RUT]
CompanyTwist Bioscience Corp
CountryUSA
IndustryDiagnostics & Research
Market Cap2.57BEPS (ttm)-3.35
P/E-EPS this Y17.01%
Forward P/E-EPS next Y15.17%
PEG-EPS past 5Y-6.09%
P/S9.26EPS next 5Y-
P/B4.58EPS Q/Q24.44%
Dividend-Sales Q/Q25.13%
Insider Own4.36%Inst Own112.82%
Insider Trans-0.56%Inst Trans2.39%
Short Float22.00%EarningsMay 02/a
Analyst Recom1.80Target Price43.38
Avg Volume932.46K52W Range11.81 - 43.21
May-03-24 03:55PM Sector Update: Health Care Stocks Mixed Late Afternoon (MT Newswires) +28.74%
01:58PM Sector Update: Health Care Stocks Mixed in Afternoon Trading (MT Newswires)
01:22PM Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised (MT Newswires)
10:02AM Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript (Insider Monkey)
06:47AM Q2 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
04:05AM Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript Highlights: Key Financial ... (GuruFocus.com)
May-02-24 09:00PM TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:35PM Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:33PM Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results (Business Wire)
WW - WW International Inc - Stock Price Chart
TickerWW [NASD, RUT]
CompanyWW International Inc
CountryUSA
IndustryPersonal Services
Market Cap159.33MEPS (ttm)-4.32
P/E-EPS this Y162.28%
Forward P/E7.33EPS next Y300.02%
PEG-EPS past 5Y-
P/S0.19EPS next 5Y15.00%
P/B-EPS Q/Q-161.28%
Dividend-Sales Q/Q-14.61%
Insider Own1.21%Inst Own82.51%
Insider Trans-4.57%Inst Trans-5.92%
Short Float21.14%EarningsMay 02/a
Analyst Recom2.43Target Price5.02
Avg Volume5.81M52W Range1.51 - 13.31
May-03-24 01:11PM WW International, Inc. (NASDAQ:WW) Q1 2024 Earnings Call Transcript (Insider Monkey) +10.58%
07:11AM Q1 2024 WW International Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 09:57PM WW Stock Earnings: WW International Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:09PM WW International Inc (WW) Q1 2024 Earnings: Misses Revenue Estimates Amidst Strategic ... (GuruFocus.com)
04:38PM WW International: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM WW (NASDAQ:WW) Surprises With Q1 Sales (StockStory)
04:01PM WW International, Inc. Announces First Quarter 2024 Results (GlobeNewswire)
May-01-24 04:30PM 7 Penny Stocks With the Potential to Make You an Overnight Millionaire (InvestorPlace)
12:38PM Stock Market Crash Warning: Don't Get Caught Holding These 3 Consumer Stocks. (InvestorPlace)
09:00AM WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care (GlobeNewswire)
ESPR - Esperion Therapeutics Inc. - Stock Price Chart
TickerESPR [NASD]
CompanyEsperion Therapeutics Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap353.62MEPS (ttm)-2.11
P/E-EPS this Y80.93%
Forward P/E41.11EPS next Y113.04%
PEG-EPS past 5Y23.09%
P/S3.04EPS next 5Y16.90%
P/B-EPS Q/Q33.60%
Dividend-Sales Q/Q71.38%
Insider Own1.10%Inst Own47.89%
Insider Trans0.00%Inst Trans5.01%
Short Float11.04%EarningsMay 07/b
Analyst Recom1.75Target Price7.41
Avg Volume6.09M52W Range0.70 - 3.40
Apr-29-24 08:00AM Esperion to Participate in Upcoming May Investor Conferences (GlobeNewswire)
Apr-23-24 08:00AM Esperion to Report First Quarter 2024 Financial Results on May 7 (GlobeNewswire) +9.42%
Apr-21-24 10:39AM 11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-07-24 02:45PM Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity (GlobeNewswire)
Apr-01-24 08:00AM Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024 (GlobeNewswire)
Mar-28-24 11:30AM Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report? (Zacks)
Mar-26-24 08:00AM Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-25-24 04:00PM Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24 (GlobeNewswire) +14.41%
Mar-22-24 06:26PM U.S. FDA Approves Broad New Labels for Esperion's NEXLETOL and NEXLIZET to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use (Business Wire) +8.53%
03:10PM U.S. FDA Approves Broad New Labels for NEXLETOL and NEXLIZET to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use (GlobeNewswire)
MRNS - Marinus Pharmaceuticals Inc - Stock Price Chart
TickerMRNS [NASD, RUT]
CompanyMarinus Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap84.11MEPS (ttm)-2.63
P/E-EPS this Y16.53%
Forward P/E-EPS next Y41.23%
PEG-EPS past 5Y6.04%
P/S2.71EPS next 5Y20.00%
P/B5.01EPS Q/Q3.42%
Dividend-Sales Q/Q0.39%
Insider Own6.40%Inst Own101.78%
Insider Trans-0.62%Inst Trans1.35%
Short Float8.83%EarningsMay 08/b
Analyst Recom1.55Target Price8.78
Avg Volume1.84M52W Range1.11 - 11.26
May-02-24 08:00AM Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference (Business Wire)
May-01-24 08:00AM Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-16-24 11:46AM Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study (Zacks) -7.69%
Apr-15-24 12:54PM Biotech on a Budget: 7 Stocks Under $10 With Huge Potential (InvestorPlace) -82.71%
11:30AM Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today? (InvestorPlace)
07:00AM Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results (Business Wire)
Apr-05-24 04:00PM Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) -10.14%
Mar-27-24 08:41AM Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review (Business Wire)
Mar-25-24 10:00AM DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-20-24 10:32AM Do Options Traders Know Something About Marinus (MRNS) Stock We Don't? (Zacks)
1⋯10⋯1314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.